Categories
presbyopia

FDA Approves Short-Distance Vision Implant

The FDA recently approved a vision implant that corrects presbyopia, the inability to focus up close. Presbyopia is often referred to as the aging eye condition because it is a common type of vision disorder that occurs as you age.

The FDA recently approved a vision implant that corrects presbyopia, the inability to focus up close. Presbyopia is often referred to as the aging eye condition because it is a common type of vision disorder that occurs as you age.

The KAMRA implant is designed for people ages 45 to 60 that can’t focus clearly on near objects, but can focus clearly on far objects. The implant gives those who must use reading glasses another option to see up close.

The FDA says the implant is not meant for people who have had cataract surgery and also not meant for people with:

– Severe dry eye
– Uncontrolled glaucoma
– Uncontrolled diabetes
– An ongoing eye infection or inflammation
– A recent or repeating herpes eye infection or complications from a previous infection
– Active autoimmune or connective tissue disease

Additionally, the implant’s labeling warns its safety and effectiveness isn’t known for those who have previously had LASIK eye surgery or other refractive procedures.

The KAMRA is an opaque ring shape and is implanted with the help of a laser that forms a pocket in the cornea into which the device is placed. The device is already available in Europe where more than 20,000 have been implanted. Of those, 362 have been removed per the patient’s request.

Source:
https://www.webmd.com/eye-health/cataracts/news/20150422/kamra-implant-presbyopia